Enveric Biosciences, Inc. (ENVB) stock
ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.51−0.01 (-0.33%)
Close on Nov 13, 2026Market cap $6.78MP/E –Yield –
Enveric Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Enveric Biosciences's price to book ratio was 0.7× on Nov 11, 2026, against 0.9× a year earlier. Over the last 2 years it ranged from 0.4× to 441.8×, with a median of 0.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | +0.2 |
| 2025 | Dec 31, 2025 | 0.5× | −236.4 |
| 2024 | Apr 30, 2024 | 236.9× | −204.9 |
| 2022 | Oct 31, 2022 | 441.8× | – |
See a number that looks wrong?